Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-12-09

Clinical Trial Update: Incontinence Analysis After HoLEP Using 28Fr Versus 22Fr Sheath [NA]

View source ↗

Summary

A clinical trial evaluating urinary incontinence after HoLEP comparing 28Fr versus 22Fr sheath has been withdrawn (NCT06068790).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Marcelino Rivera | Conditions: Urinary Incontinence | NA | Status: WITHDRAWN